KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Weighted Average) (2016 - 2025)

Medpace Holdings' Shares Outstanding (Weighted Average) history spans 11 years, with the latest figure at $28.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 6.82% year-over-year to $28.8 million; the TTM value through Dec 2025 reached $28.8 million, down 6.82%, while the annual FY2025 figure was $28.8 million, 6.82% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $28.8 million in Q4 2025 per MEDP's latest filing, down from $29.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $35.9 million in Q4 2021 to a low of $28.6 million in Q2 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $31.9 million, with a median of $31.0 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): decreased 13.42% in 2022, then increased 1.36% in 2024.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $35.9 million in 2021, then decreased by 9.69% to $32.4 million in 2022, then fell by 5.14% to $30.7 million in 2023, then increased by 0.76% to $31.0 million in 2024, then decreased by 6.82% to $28.8 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Shares Outstanding (Weighted Average) are $28.8 million (Q4 2025), $29.0 million (Q3 2025), and $28.6 million (Q2 2025).